机译:诱导化疗随后是喉部喉癌和白阴性癌症的放射治疗:基于临床评价的分数,基于计算机断层摄影的体积和F-18-FDG-PET / CT进行了一次循环诱导化疗后的结果预测
Univ Leipzig Dept Otolaryngol Head &
Neck Surg Leipzig Germany;
Univ Leipzig Dept Otolaryngol Head &
Neck Surg Leipzig Germany;
Univ Leipzig Dept Otolaryngol Head &
Neck Surg Leipzig Germany;
Univ Leipzig Dept Otolaryngol Head &
Neck Surg Leipzig Germany;
Univ Leipzig Dept Otolaryngol Head &
Neck Surg Leipzig Germany;
Univ Leipzig Dept Otolaryngol Head &
Neck Surg Leipzig Germany;
Univ Leipzig Dept Otolaryngol Head &
Neck Surg Leipzig Germany;
Univ Leipzig Dept Nucl Med Leipzig Germany;
Univ Leipzig Dept Diagnost &
Intervent Radiol Leipzig Germany;
Univ Leipzig Dept Nucl Med Leipzig Germany;
Univ Leipzig Dept Otolaryngol Head &
Neck Surg Leipzig Germany;
Univ Leipzig Dept Nucl Med Leipzig Germany;
Head and neck cancer; Laryngeal cancer; Hypopharyngeal cancer; Larynx preservation; HNSCC; Induction chemotherapy; Early response evaluation; F-18-FDG; PET/CT; Decision-making;
机译:诱导化疗随后是喉部喉癌和白阴性癌症的放射治疗:基于临床评价的分数,基于计算机断层摄影的体积和F-18-FDG-PET / CT进行了一次循环诱导化疗后的结果预测
机译:紫杉醇和顺铂诱导化疗后放疗用于晚期喉癌和下咽癌的喉器官保存可提供中度晚期毒性结果(DeLOS-I-trial)
机译:感应化疗(IC)随后是放疗(RT)与甲磺酸/后癌症和室温下的RT可转移只能通过喉喉射精术最终结果进行可转让的喉头植物保存试验DELOS-II
机译:使用单光子发射计算机断层扫描(SPECT)与〜(99米)TC-MIBI进行评估喉喉癌和喉癌治疗的新辅助化疗效果
机译:吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
机译:IVA-B期口咽或下咽癌患者的诱导化疗及放化疗采用容积调制弧光疗法作为器官保存方法的长期结果
机译:后咽癌诱导化疗后的定义放疗:基于对诱导化疗的反应,选择用于器官保存治疗的候选者